Global Breast Imaging Market Assessment 2020-2025: Opportunities, Challenges, and Details of the Competitive Landscape


Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "Breast Imaging Market by Technology [Mammography (FFDM, Digital & 3D Mammography), Breast Ultrasound, MRI, CBCT, MBI, PET-CT, ABUS, Optical Imaging], End user (Hospitals & Clinics, Breast Care Centers, Diagnostic Imaging Centers) - Global Forecasts to 2025" report has been added to's offering.

Global Breast Imaging Market Projected to Reach USD 5.4 Billion by 2025 from USD 3.7 Billion in 2020, at a CAGR of 8.1%

The growth of the market is attributed to the rising incidence of breast cancer in women. According to GLOBOCON 2018, breast cancer is the most common cancer among women and one of the most important causes of death. In 2018, 2,088,849 breast cancer cases were diagnosed globally.

Furthermore, growth in the geriatric population (as age contributes to the risk of breast cancer) and changing lifestyles, which have increased the overall possibility of cancer occurrence, presence of favorable reimbursement scenario, and implementation of breast density laws in major regions will further fuel the growth of the market in near future.

However, the side-effects of radiation exposure and the growing adoption of refurbished imaging systems are the major factors that are expected to restrain the growth of this market during the forecast period.

The ionizing breast imaging segment is expected to account for the largest market share during the forecast period

Based on technology, the market is segmented into ionizing imaging technologies and non-ionizing imaging technologies. Ionizing imaging technologies segment is categorized into five subsegments, namely, mammography (analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis), positron emission tomography-computed tomography (PET-CT), molecular breast imaging/breast-specific gamma imaging (MBI/BSGI), positron emission mammography (PEM), and cone-beam computed tomography (CBCT) technology.

While, the non-ionizing breast imaging technologies market is further sub-segmented into breast MRI, breast ultrasound, automated whole-breast ultrasound (AWBU), breast thermography, electric impedance tomography, and optical imaging technologies. The ionizing breast imaging segment accounted for the largest share of this market in 2019, driven by the technological advancements in ionizing breast imaging technologies and rising awareness about the early screening and diagnosis of breast cancer.

The mammography segment to hold a major share of the breast imaging market over the market throughout the forecast period

Based on type, the mammography market is segmented into three major types-full-field digital mammography, analog mammography, and 3D breast tomosynthesis. Rising R&D by the key players operating in the market, technological advancements coupled with favorable reimbursement scenario in most of the developed countries is driving the growth of the mammography segment.

Europe to account for the second-largest share of the global market in 2019

The breast imaging market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and Middle East and Africa. Europe accounted for the second-largest share of the breast imaging market in 2019.

The growth of the breast imaging market in Europe is mainly driven by factors such as the increasing incidence of breast cancer and awareness regarding early breast cancer detection. Furthermore, factors such as the increasing number of regulatory approvals for advanced breast imaging modalities and the growing number of distribution collaborations and partnerships among market players are also supporting the growth of this market.

Research Coverage

This report studies the breast imaging market based on technology, end-user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders.

Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Market Dynamics

  • Drivers
    • Growing Incidence of Breast Cancer
    • Increasing Public-Private Investments, Funding, and Grants
    • Growing Awareness Regarding Early Detection of Breast Cancer
    • Technological Advancements in Breast Imaging Modalities
    • Growing Aging Population
  • Restraints
    • High Cost of Breast Imaging Systems
    • Stringent Regulatory Approval Procedures
  • Opportunities
    • Emerging Economies Offer High Growth Potential
    • Contract-based Diagnostic Solutions and Mobile Solutions
  • Challenges
    • Side Effects of Radiation Exposure
    • Errors in Breast Cancer Screening and Diagnosis
    • Increasing Adoption of Refurbished Imaging Systems
  • Trends
    • Artificial Intelligence
    • Personalized Approach to Breast Cancer Screening
    • Multimodal Breast Imaging
    • Screening Guidelines for Breast Cancer

Companies Mentioned

  • Allengers
  • Aurora Healthcare US Corp.
  • Canon Inc.
  • Carestream Health
  • CMR Naviscan
  • Cura Healthcare
  • Delphinus Medical Technologies, Inc.
  • Dilon Technologies, Inc.
  • Fujifilm Holdings Corporation
  • GE Healthcare (a Part of General Electric Company)
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Kub Technologies
  • Micrima Limited
  • NP JSC Amico
  • Planmed Oy
  • QT Ultrasound LLC
  • Siemens Healthcare (a Part of Siemens AG)
  • Sonocine
  • Supersonic Imagine

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Contact Data